Blood Podcast cover image

BMT as initial treatment for severe aplastic anemia, macrophage metabolic rewiring in sickle cell disease, and predicting outcomes using PET radiomics in diffuse large B cell lymphoma

Blood Podcast

00:00

Baseline Pet Radiomics Outperform the IPI Risk Score for Prediction of Outcome in Diffuse Large B-Cell Lymphoma

impaired epharocytosis is the key driver of hepatic damage and chronic inflammation in sickle cell disease. Hemolysis plays a major role in this process by reprogramming macrophages towards highly inflammatory cells. Reversing these defects through reactivation of the PPAR-gamma PGC-1-alpha pathway leads to a therapeutic benefit for SCD.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app